ALNY - Alnylam Pharmaceuticals Inc. (ALNY) CEO Yvonne Greenstreet on Q1 2022 Results - Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2022 Earnings Conference Call April 28, 2022 08:30 AM ET Company Participants Christine Lindenboom - Senior Vice President of Investor Relations and Corporate Communications Yvonne Greenstreet - Chief Executive Officer Tolga Tanguler - Chief Commercial Officer Pushkal Garg - Chief Medical Officer Jeff Poulton - Chief Financial Officer Conference Call Participants David Lebowitz - Citigroup Maury Raycroft - Jefferies Salveen Richter - Goldman Sachs Paul Matteis - Stifel Matthew Harrison - Morgan Stanley Ritu Baral - Cowen Tazeen Ahmad - Bank of America Gena Wang - Barclays Anupam Rama - JPMorgan Presentation Operator Good day, and thank you for standing by. Welcome to the Alnylam Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised today’s conference may be recorded. [Operator Instructions] I’d now
For further details see:
Alnylam Pharmaceuticals, Inc. (ALNY) CEO Yvonne Greenstreet on Q1 2022 Results - Earnings Call Transcript